COMMUNIQUÉS West-GlobeNewswire

Seelos Therapeutics Completes Acquisition of Trehalose from Bioblast Pharma
19/02/2019
Diversifies Seelos’ pipeline in rare diseases Collaborates with Team Sanfilippo Foundation in development of Trehalose in Sanfilippo syndrome NEW YORK, Feb. 19, 2019 (GLOBE NEWSWIRE) -- Seelos Therapeutics, Inc. (Nasdaq [...]
Dova Pharmaceuticals to Present at the 8th Annual SVB Leerink Global Healthcare Conference
19/02/2019
DURHAM, N.C., Feb. 19, 2019 (GLOBE NEWSWIRE) -- Dova Pharmaceuticals, Inc. (NASDAQ: DOVA) today announced that Dr. David Zaccardelli, President and Chief Executive Officer, will present a company overview at the 8 th [...]
Assertio Therapeutics Announces Appointment of Heather L. Mason to Board of Directors
19/02/2019
LAKE FOREST, Ill., Feb. 19, 2019 (GLOBE NEWSWIRE) -- Assertio Therapeutics, Inc. (NASDAQ: ASRT) announced today that Heather L. Mason has been appointed to the Company’s Board of Directors. Ms. Mason is a former [...]
Rexahn Presents Updated Interim Data From Phase 2a Trial of RX-3117 in Advanced Bladder Cancer at the 2019 ASCO GU Symposium
19/02/2019
Encouraging Preliminary Signs of Efficacy, Including One Complete Response, Observed in Patients With Advanced Bladder Cancer Who Have Progressed on Multiple Prior Treatments Including Immunotherapy and Gemcitabine [...]
AMAG Pharmaceuticals to Present at Leerink Partners Global Healthcare Conference
19/02/2019
WALTHAM, Mass., Feb. 19, 2019 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) will present at the Leerink Partners Global Healthcare Conference on Wednesday, February 27, 2019. Ted Myles, chief financial [...]
Spectral Announces Approval of Tigris Trial by the US FDA
19/02/2019
TORONTO, Feb. 19, 2019 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (“Spectral” or the “Company”) (TSX: EDT) , a Phase III company developing the first treatment for patients with endotoxemic septic shock guided by a [...]
electroCore and HealthyWomen Announce Partnership on Patient Program to Increase Awareness of Non-Drug Migraine Therapies
19/02/2019
BASKING RIDGE, N.J. and NEW YORK, Feb. 19, 2019 (GLOBE NEWSWIRE) -- electroCore, Inc . (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, today announced a patient education initiative in partnership [...]
La société Medexus Pharmaceuticals organise une conférence téléphonique sur le troisième trimestre de l’exercice 2019
19/02/2019
Elle retient les services de Crescendo Communications pour les services de relations avec les investisseurs La conférence téléphonique aura lieu à 16 h 30 heure de l’Est le lundi 25 février 2019 MONTRÉAL, 19 févr. 2019 [...]
Immunomedics to Report Results for the Quarter and Six Months Ended December 31, 2018 and Host Conference Call and Webcast on February 25, 2019
19/02/2019
MORRIS PLAINS, N.J., Feb. 19, 2019 (GLOBE NEWSWIRE) -- Immunomedics, Inc. , (NASDAQ: IMMU) (“Immunomedics” or the “Company”), a leading biopharmaceutical company in the area of antibody-drug conjugates (ADC), today [...]
CymaBay Therapeutics Announces Early Enrollment of a Phase 2b Study of Seladelpar in Patients with Nonalcoholic Steatohepatitis
19/02/2019
Total of 181 subjects enrolled with elevated liver fat and biopsy-confirmed NASH Over 80 % of subjects had baseline F2 or F3 stage fibrosis Subjects were randomized to seladelpar 10 mg, 20 mg or 50 mg or placebo Twelve- [...]
Private Placement of $366,666
19/02/2019
MONTRÉAL, Feb. 19, 2019 (GLOBE NEWSWIRE) -- TERRANUEVA CORPORATION (“Terranueva” or the “Company”) is pleased to announce that it has completed a private placement for an aggregate amount of $366,666 in common shares at [...]
Placement privé de 366 666 $
19/02/2019
MONTRÉAL, 19 févr. 2019 (GLOBE NEWSWIRE) -- CORPORATION TERRANUEVA (la « Société » ou « Terranueva ») est heureuse d’annoncer avoir complété un placement privé d’une somme globale de 366 666 $ en actions ordinaires au [...]
Allakos Announces Positive Phase 1 Results with AK002 in Indolent Systemic Mastocytosis
19/02/2019
AK002 has now shown clinical activity in multiple mast cell diseases REDWOOD CITY, Calif., Feb. 19, 2019 (GLOBE NEWSWIRE) -- Allakos Inc. (NASDAQ: ALLK), a biotechnology company developing AK002 for the treatment of [...]
Strongbridge Biopharma plc to Host Fourth Quarter and Year-End 2018 Financial Results Conference Call on February 26, 2019
19/02/2019
DUBLIN, Ireland and TREVOSE, Pa., Feb. 19, 2019 (GLOBE NEWSWIRE) -- Strongbridge Biopharma plc, (Nasdaq: SBBP), a global commercial-stage biopharmaceutical company focused on the development and commercialization of [...]
Amedisys Announces Retirement of Board Member Linda J. Hall
19/02/2019
BATON ROUGE, La., Feb. 19, 2019 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED), America’s leading independent home health, hospice and personal care company, announced today that Ms. Linda J. Hall, Ph.D., will retire [...]
Spark Therapeutics Reports 2018 Financial Results and Recent Business Progress
19/02/2019
PHILADELPHIA, Feb. 19, 2019 (GLOBE NEWSWIRE) -- Spark Therapeutics (NASDAQ: ONCE), a fully integrated, commercial gene therapy company dedicated to challenging the inevitability of genetic disease, announced today [...]
Iterum to Present at the 8th Annual SVB Leerink Partners Global Healthcare Conference
19/02/2019
DUBLIN, Ireland and CHICAGO, Feb. 19, 2019 (GLOBE NEWSWIRE) -- Iterum Therapeutics plc (Nasdaq: ITRM), a clinical-stage pharmaceutical company developing antibiotics against multi-drug resistant pathogens, today [...]
Aptose to Present at the 8th Annual SVB Leerink Global Healthcare Conference
19/02/2019
SAN DIEGO and TORONTO, Feb. 19, 2019 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (Nasdaq: APTO; TSX: APS), a clinical-stage company developing highly differentiated therapeutics that target the underlying mechanisms of [...]
Aptinyx Initiates Phase 2 Study to Evaluate Safety and Efficacy of NYX-783 in Patients with Post-Traumatic Stress Disorder
19/02/2019
Favorable safety and tolerability, linear pharmacokinetics, and ample CNS exposure of NYX-783 observed in Phase 1 Phase 2 data anticipated 1H 2020 EVANSTON, Ill., Feb. 19, 2019 (GLOBE NEWSWIRE) -- Aptinyx Inc. (NASDAQ: [...]

Pages